Comparative study on the virulence of mycobacteriophages.

Autor: Rubino I; Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Alberta, Canada.; Département de Génie Chimique et de Génie Biotechnologique, Université de Sherbrooke, Sherbrooke, Québec, Canada., Guerrero-Bustamante CA; Department of Biological Sciences, University of Pittsburgh, Pennsylvania, USA., Harrison M; Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Alberta, Canada., Co S; Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Alberta, Canada., Tetreau I; Department of Mechanical Engineering, University of Alberta, Edmonton, Alberta, Canada., Ordoubadi M; Department of Mechanical Engineering, University of Alberta, Edmonton, Alberta, Canada., Larsen SE; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA., Coler RN; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA.; University of Washington School of Medicine, Department of Pediatrics, Seattle, WA, USA.; University of Washington, Department of Global Health, Seattle, WA, USA., Vehring R; Department of Mechanical Engineering, University of Alberta, Edmonton, Alberta, Canada., Hatfull GF; Department of Biological Sciences, University of Pittsburgh, Pennsylvania, USA., Sauvageau D; Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Alberta, Canada.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2024 Oct 29. Date of Electronic Publication: 2024 Oct 29.

Antibodies as key mediators of protection against Mycobacterium tuberculosis .

Autor: Wang Q; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, United States., Nag D; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, WA, United States., Baldwin SL; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, WA, United States., Coler RN; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle, WA, United States.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, United States.; Department of Global Health, University of Washington, Seattle, WA, United States., McNamara RP; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Sep 02; Vol. 15, pp. 1430955. Date of Electronic Publication: 2024 Sep 02 (Print Publication: 2024).

Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming.

Autor: Williams BD; Department of Global Health, University of Washington, Seattle, WA, United States.; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States., Ferede D; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States., Abdelaal HFM; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States., Berube BJ; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States.; HDT Bio Corp, Seattle, WA, United States., Podell BK; Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, United States., Larsen SE; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States., Baldwin SL; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States., Coler RN; Department of Global Health, University of Washington, Seattle, WA, United States.; Seattle Children's Research Institute, Center for Global Infectious Disease Research, Seattle Children's, Seattle, WA, United States.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, United States.

Publikováno v: Frontiers in immunology [Front Immunol] 2024 Jun 20; Vol. 15, pp. 1424374. Date of Electronic Publication: 2024 Jun 20 (Print Publication: 2024).

Cryogenic transmission electron microscopy of recombinant tuberculosis vaccine antigen with anionic liposomes reveals formation of flattened liposomes

Autor: Fox CB, Mulligan SK, Sung J, Dowling QM, Fung HWM, Vedvick TS, Coler RN

Publikováno v: International Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 1367-1377 (2014)

Christopher B Fox,1 Sean K Mulligan,2 Joyce Sung,2 Quinton M Dowling,1 H W Millie Fung,1 Thomas S Vedvick,1 Rhea N Coler1 1Infectious Disease Research Institute, Seattle, WA, USA; 2NanoImaging Services, La Jolla, CA, USA Abstract: Development of lipi

Externí odkaz: https://doaj.org/article/7a94eed1e6e1406d8c94dc13903fbb4a

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.

Autor: Lyke KE; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA. klyke@som.umaryland.edu., Atmar RL; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA. ratmar@bcm.edu., Dominguez Islas C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Posavad CM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Laboratory Medicine & Pathology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Deming ME; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Branche AR; Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, NY, USA., Johnston C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Laboratory Medicine & Pathology, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA., El Sahly HM; Departments of Medicine and Molecular Virology & Microbiology, Baylor College of Medicine, Houston, TX, USA., Edupuganti S; Department of Medicine, Emory University School of Medicine, Atlanta, USA.; Hope Clinic of Emory Vaccine Center, Atlanta, GA, USA., Mulligan MJ; NYU Langone Vaccine Center and Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA., Jackson LA; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA., Rupp RE; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX, USA., Rostad CA; Department of Pediatrics and Center for Childhood Infections and Vaccines, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, USA., Coler RN; Seattle Children's Research Institute, University of Washington School of Medicine, Seattle, WA, USA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA., Bäcker M; NYU Langone Hospital-Long Island Vaccine Center Research Clinic and Division of Infectious Disease, Department of Medicine, NYU Long Island School of Medicine, Mineola, NY, USA., Kottkamp AC; NYU Langone Vaccine Center and Division of Infectious Diseases and Immunology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA., Babu TM; Department of Medicine, University of Washington, Seattle, WA, USA., Dobrzynski D; Department of Medicine, Division of Infectious Diseases, University of Rochester, Rochester, NY, USA., Martin JM; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Brady RC; Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Frenck RW Jr; Cincinnati Children's Hospital Medical Center, Division of Infectious Diseases, University of Cincinnati College of Medicine, Cincinnati, OH, USA., Rajakumar K; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Kotloff K; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Rouphael N; Department of Medicine, Emory University School of Medicine, Atlanta, USA.; Hope Clinic of Emory Vaccine Center, Atlanta, GA, USA., Szydlo D; Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, USA., PaulChoudhury R; Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Archer JI; FHI360, Durham, NC, 27701, USA., Crandon S; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Ingersoll B; Statistical Center for HIV/AIDS Research and Prevention (SCHARP), Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Eaton A; Department of Surgery, Duke University Medical Center, Durham, NC, USA., Brown ER; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA., Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA., Stephens DS; Department of Medicine, Emory University School of Medicine, Atlanta, USA., Post DJ; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Lin BC; Vaccine Immunology Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Serebryannyy L; Vaccine Immunology Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Beigel JH; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, NC, USA.; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC, USA., Roberts PC; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2023 Jul 11; Vol. 8 (1), pp. 98. Date of Electronic Publication: 2023 Jul 11.